RocketTickers

Regeneron Announces Encouraging Topline Phase 2 Data of High-dos

Long
NASDAQ:REGN   Regeneron Pharmaceuticals, Inc
REGN: Regeneron Pharmaceuticals , Inc.
2021-08-24 07:00:00
Regeneron Announces Encouraging Topline Phase 2 Data of High-dose aflibercept in Wet Age-related Macular Degeneration